2S-3-3S4S-3-1R-1--4-4--3-1-5--2--3--3--1--3--12- CRYSTALLINE 2S-3-3S4S-3-1R-1-HYDROXYETHYL-4-4-METHOXY-3-1-5-METHYLPYRIDIN-2-YLAZETIDIN-3-YLOXYPHENYL-3-METHYLPYRROLIDIN-1-YL-3-OXOPROPANE-12-DIOL

摘要

The present invention relates to crystalline (2S) -3 - [(3S, 4S) -3 - [(1R) -1-hydroxyethyl] -4- 2-yl) azetidin-3-yl] oxy} phenyl) -3-methylpyrrolidin-1-yl] -3-oxopropane-1,2-diol and pharmaceutical compositions thereof. The present invention also provides a method of using this compound for the treatment of an overactive bladder.